Pyxis Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	208	80	47	359	-	-
Market Cap Growth	67.00%	69.64%	-86.91%	-	-	-
Enterprise Value	67	-20	-115	83	-7	-20
PE Ratio	-	-1.08	-0.39	-4.73	-	-
PS Ratio	12.69	-	-	-	-	-
PB Ratio	1.11	0.64	0.29	1.38	-	-
P/FCF Ratio	-3.69	-1.03	-0.49	-10.02	-	-
P/OCF Ratio	-3.83	-1.13	-0.53	-10.17	-	-
EV/Sales Ratio	4.16	-	-	-	-	-
EV/EBITDA Ratio	-2.03	0.28	0.97	-1.12	0.61	7.10
EV/EBIT Ratio	-1.90	0.27	0.95	-1.10	0.57	7.10
EV/FCF Ratio	-1.64	0.25	1.20	-2.32	0.63	8.79
Debt / Equity Ratio	0.11	0.17	0.12	0.00	-0.05	-0.01
Debt / EBITDA Ratio	-0.38	-0.30	-0.16	0.00	-0.07	-0.01
Debt / FCF Ratio	-0.31	-0.28	-0.20	0.00	-0.07	-0.01
Quick Ratio	11.77	4.69	5.71	14.76	2.19	26.86
Current Ratio	12.19	4.84	5.90	14.90	2.20	26.88
Asset Turnover	0.09	0	0	0	0	-
Return on Equity (ROE)	-39.00%	-52.60%	-60.70%	-61.90%	138.50%	-
Return on Assets (ROA)	-30.60%	-41.10%	-51.90%	-52.40%	-85.60%	-
Return on Capital (ROIC)	-32.62%	-55.90%	-68.70%	-26.66%	86.74%	100.70%
Earnings Yield	-28.21%	-92.49%	-256.68%	-21.14%	-	-
FCF Yield	-32.76%	-97.06%	-203.56%	-9.98%	-	-
Buyback Yield / Dilution	-45.08%	-20.80%	-288.93%	-724.14%	75.88%	-
Total Shareholder Return	-45.08%	-20.80%	-288.93%	-724.14%	75.88%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).